Sunil Kumar, Gaurav Sharma, Mathew George and Lincy Joseph 1. VANDETANIB A NEW DRUG FOR METASTATIC MEDULLARY THYROID CANCER. International Journal of Pharma Professional’s Research (IJPPR). 2, 3 (1), 351-353.